Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 10;15(6):1392.
doi: 10.3390/polym15061392.

Phytochemical-Based Nanomaterials against Antibiotic-Resistant Bacteria: An Updated Review

Affiliations
Review

Phytochemical-Based Nanomaterials against Antibiotic-Resistant Bacteria: An Updated Review

Rocío Díaz-Puertas et al. Polymers (Basel). .

Abstract

Antibiotic-resistant bacteria (ARB) is a growing global health threat, leading to the search for alternative strategies to combat bacterial infections. Phytochemicals, which are naturally occurring compounds found in plants, have shown potential as antimicrobial agents; however, therapy with these agents has certain limitations. The use of nanotechnology combined with antibacterial phytochemicals could help achieve greater antibacterial capacity against ARB by providing improved mechanical, physicochemical, biopharmaceutical, bioavailability, morphological or release properties. This review aims to provide an updated overview of the current state of research on the use of phytochemical-based nanomaterials for the treatment against ARB, with a special focus on polymeric nanofibers and nanoparticles. The review discusses the various types of phytochemicals that have been incorporated into different nanomaterials, the methods used to synthesize these materials, and the results of studies evaluating their antimicrobial activity. The challenges and limitations of using phytochemical-based nanomaterials, as well as future directions for research in this field, are also considered here. Overall, this review highlights the potential of phytochemical-based nanomaterials as a promising strategy for the treatment against ARB, but also stresses the need for further studies to fully understand their mechanisms of action and optimize their use in clinical settings.

Keywords: antimicrobial; electrospinning; green synthesis; nanofibers; nanoparticles; nanotechnology; plants.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Main bacterial molecular targets of phytochemicals with antibacterial activity.
Figure 2
Figure 2
Diagram of electrospinning process for the manufacturing of NFs loaded with plant extracts.
Figure 3
Figure 3
Schematic diagram of the different methods of synthesis (dispersion of preformed polymers, polymerization of monomers, coacervation/ionic gelation, green synthesis) of polymeric NPs.
Figure 4
Figure 4
Schematic representation of the methodology used in the green synthesis of metallic nanoparticles using plant extracts.

Similar articles

Cited by

References

    1. Murray C.J.L., Ikuta K.S., Sharara F., Swetschinski L., Robles Aguilar G., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed
    1. Huemer M., Mairpady Shambat S., Brugger S.D., Zinkernagel A.S. Antibiotic resistance and persistence—Implications for human health and treatment perspectives. EMBO Rep. 2020;21:e51034. doi: 10.15252/embr.202051034. - DOI - PMC - PubMed
    1. Malik B., Bhattacharyya S. Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci. Rep. 2019;9:9788. doi: 10.1038/s41598-019-46078-y. - DOI - PMC - PubMed
    1. Hays J.P., Ruiz-Alvarez M.J., Roson-Calero N., Amin R., Murugaiyan J., van Dongen M.B.M., Global A.M.R.I.A.N. Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics. Infect. Dis. Ther. 2022;11:1315–1326. doi: 10.1007/s40121-022-00656-2. - DOI - PMC - PubMed
    1. Avershina E., Shapovalova V., Shipulin G. Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. Front. Microbiol. 2021;12:2044. doi: 10.3389/fmicb.2021.707330. - DOI - PMC - PubMed

LinkOut - more resources